Navigation Links
Amarantus BioScience Secures an Additional $1.4 Million in Financing Commitments
Date:1/31/2013

SUNNYVALE, Calif., Jan. 31, 2013 /PRNewswire/ -- Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated with the neurodegeneration and apoptosis centered around its patented therapeutic protein MANF, today announced it has secured an additional $1.4 million of financing commitments through an amendment of the initial Convertible Note with Dominion Capital.  The original $600,000 note, dated November 14, 2012, was amended to a face value of $2,000,000 before deducting placement agent fees and other offering expenses.  Proceeds will be used to provide funding for Amarantus' lead asset Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF"), the advancement of the Company's diagnostic platforms, and for general working capital. 

"With our recently reported positive efficacy data on MANF, and our newly acquired diagnostic platforms, this additional funding positions Amarantus to advance these assets for the potential treatment and diagnosis of Parkinson's disease and other apoptosis-related disorders," said Gerald E. Commissiong , President and CEO of Amarantus.  "This also provides us the opportunity to explore additional indications where our product candidates may be beneficial." 

In November 2012, Amarantus issued a Convertible Promissory Note to Dominion Capital, LLC in the principal amount of $600,000. On January 28, 2013, the note was amended to increase the principal amount of the note to $2,000,000.  The Note bears interest at the rate of ten percent (10%) per annum, is convertible into common stock at $0.10 per share, and is pre-payable at the company's option at any time. The financing commitments will be realized by Amarantus under the note in six separate tranches of $200,000 to $250,000, subject to certain milestone achievements. Dominion has agreed t
'/>"/>

SOURCE Amarantus Bioscience, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
2. Amarantus BioSciences Announces MANF Demonstrates Superiority over GDNF in Neurorestoration Behavioural Animal Model of Parkinsons Disease
3. Amarantus BioSciences Appoints Amgen Co-Founder Dr. Joseph Rubinfeld to Advisory Board
4. Amarantus Biosciences and RBCC Outline Terms for NuroPro Parkinsons Blood Test Joint Venture
5. Amarantus BioSciences Appoints Dr. Robert J. Zimmerman as Product Development Advisor
6. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
7. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
8. Neurocrine Biosciences Reports First Quarter 2012 Results
9. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
10. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
11. Neurocrine Biosciences to Present at the Jefferies 2012 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... -- Texas, premier physician associations today announced the establishment of ... need to provide demonstrably better and more efficient patient ... "I am confident the Physician Services Organization for ... Stephen L. Brotherton , MD, president of the ... doctors are determined to make health care better and ...
(Date:5/23/2013)... 2013  Ameritox, the nation,s leader in pain ... Inc. to become part of its Urine Drug ... costs and improve the clinical outcomes for injured ... benefit manager in the workers, compensation industry, has ... pain management strategy for several years. By establishing ...
(Date:5/23/2013)... Medical Systems, Inc. (NASDAQ: CASM ) (CASMED), a ... that Thomas M. Patton , President and ... Annual Marcum MicroCap Conference on Thursday, May 30, 2013, at ... . The presentation is scheduled to begin ... will be available via a live webcast at http://wsw.com/webcast/marcum/casm/ ...
Breaking Medicine Technology:TMA Launches Physician Services Organization for Patient Care 2TMA Launches Physician Services Organization for Patient Care 3TMA Launches Physician Services Organization for Patient Care 4Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers 2Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers 3CASMED to Present at the 2nd Annual Marcum MicroCap Conference 2
... VILLAGE, Calif., Dec. 21 Specialists On Call, ... 10,000th emergency teleneurology consultation since the company,s inception. ... SOC,s leadership position as the largest private emergency teleneurology ... when it recently responded to a neurologic emergency at ...
... , LJUBLJANA, Slovenia, Dec. 21 Slovenian Minister of ... Novalis Tx(TM) radiosurgery platform for modern radiotherapy and radiosurgery ... platform from Varian Medical Systems (NYSE: VAR ... the country,s only radiotherapy department access to advanced radiotherapy ...
Cached Medicine Technology:Specialists On Call Delivers 10,000th Emergency Teleneurology Consultation 2Specialists On Call Delivers 10,000th Emergency Teleneurology Consultation 3Slovenia's Sole Radiotherapy Hospital Unveils Novalis Tx(TM) Platform From Varian and BrainLAB 2Slovenia's Sole Radiotherapy Hospital Unveils Novalis Tx(TM) Platform From Varian and BrainLAB 3Slovenia's Sole Radiotherapy Hospital Unveils Novalis Tx(TM) Platform From Varian and BrainLAB 4
(Date:5/25/2013)... May 25, 2013 A disorder of ... of peripheral neuropathy. According to neuropathy expert doctor Helen ... is estimated that the disorder affects almost 50% of ... arising from Diabetes. The high blood sugar levels in ... patients suffering from it usually tend to have abnormally ...
(Date:5/25/2013)... May 25, 2013 Radius Engineering ... shelter company in the US and has been ... for over 35 years. M.E. and President, Walton ... of NBC Weapon Fundamentals and Shelter Engineering Standards, ... bible on shelter engineering. McCarthy is considered the ...
(Date:5/25/2013)... May 25, 2013 Pradaxa lawsuits ... life-threatening episodes of internal bleeding while using the blood thinner ... District Court, Southern District of Illinois, Bernstein Liebhard LLP reports. ... Pradaxa side effect claims had been filed in ... from 705 claims reported by the Court on May 15th. ...
(Date:5/25/2013)... Many orthodontists have thought about moving ... that cloud is. Most people would naturally assume ... provide their cloud service and support would own and ... they're selling, they'd be wrong. Cloud providers lease ... redundant facility that houses servers and related equipment to ...
(Date:5/25/2013)... CA (PRWEB) May 25, 2013 IBISWorld estimates ... grow at an average annual rate of 28.7% to $1.0 ... 17.9% in 2013. From 2002 and 2008, no new cell ... Culbert, causing relatively modest growth during that period. In the ... approved six new products. This factor contributed to the industry's ...
Breaking Medicine News(10 mins):Health News:Diabetic Neuropathy treatment hits new grounds- Neuracel launches the complete natural treatment 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 3Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 2Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 3Health News:Cirrus Ortho Launches Cloud Computing for Orthodontic Industry That is Unlike Any Other 2Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 3
... , Cancer Treatment Centers ... from Italy , PHILADELPHIA, Nov. 18 A radiation ... to the current average of six weeks, has arrived at ... CTCA will become the first in the country to offer this ...
... , , NEW YORK, Nov. ... kids, featuring reviews and commentary about products, discoveries on the ... kids behind WAT,s-THE-WORD?! are four young boys who helped their ... Cameron, age 10, recommended to his mom a "cooler" and ...
... , AUSTIN, Texas, Nov. 18 The Advisory Board of ... launch of a new online community for athletes overcoming accident, ... forum where athletes can share stories, set goals and report ... by providing encouragement, advice and mentoring. , IWillAgain.com is inspired ...
... , CALGARY, Nov. 18 /PRNewswire-FirstCall/ - Oncolytics ... announced today that it has entered into an underwriting agreement ... common share and 0.4 of a common share purchase warrant, ... proceeds of US$12,750,000. Each whole common share purchase warrant entitles ...
... , , WASHINGTON, Nov. 18 ... a wholly owned subsidiary of ULLICO Inc., a privately ... Prescription Solutions will provide pharmacy benefit management services to ... union trust funds, union employers and their members with ...
... 300 million patients use non-steroidal anti-inflammatory drugs (NSAIDs) in ... diseases. Nearly 30% of the users suffer from gastric ... the stomach, misoprostol, a non-selective prostaglandin E1 (PGE1) analogue, ... of NSAID-induced injuries, but often induces severe adverse effects. ...
Cached Medicine News:Health News:Radiation Breakthrough Gives Breast Cancer Patients Hope in Single Dose 2Health News:Radiation Breakthrough Gives Breast Cancer Patients Hope in Single Dose 3Health News:WAT-AAH!, The First Functional Bottled Water For Kids, Announces The Release of WAT's-THE-WORD?! 2Health News:IWillAgain.com Launches Online Community for Athletes Overcoming Accident, Illness or Injury 2Health News:Oncolytics Biotech(R) Inc. Announces Terms of Unit Offering 2Health News:Oncolytics Biotech(R) Inc. Announces Terms of Unit Offering 3Health News:Oncolytics Biotech(R) Inc. Announces Terms of Unit Offering 4Health News:Union Labor Life Selects Prescription Solutions To Provide Pharmacy Benefit Management Services 2Health News:Union Labor Life Selects Prescription Solutions To Provide Pharmacy Benefit Management Services 3
... Leptin is a proteohormone with a molecular weight ... by the ob gene and produced by adipocytes [1,2]. ... in the regulation of body weight [1-3]. In ... in both men and women [4]. A relationship ...
ACTIVATED CLOTTING TIME SYSTEM...
... CT is a completely automated, ... performing clotting assays in random ... method of sample management offers ... of STAT samples without the ...
... ACTH (adrenocorticotropic hormone) is synthesized in the ... and is secreted into the peripheral circulation, ... 20 minutes [1]. ACTH is secreted in ... hypothalamus [1]. The actions of CRF are ...
Medicine Products: